Haemonetics Corp
NYSE:HAE
Haemonetics Corp
Cash from Financing Activities
Haemonetics Corp
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Haemonetics Corp
NYSE:HAE
|
Cash from Financing Activities
$100.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Financing Activities
$116m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Financing Activities
-$338m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-4%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Financing Activities
-$598.3m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-34%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Financing Activities
-$21.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
See Also
What is Haemonetics Corp's Cash from Financing Activities?
Cash from Financing Activities
100.1m
USD
Based on the financial report for Dec 30, 2023, Haemonetics Corp's Cash from Financing Activities amounts to 100.1m USD.